Zinc lozenges may shorten common cold duration
Zinc lozenges may shorten the duration of common cold episodes by up to 40 per cent, according to a new systematic review of the evidence.
Zinc lozenges may shorten the duration of common cold episodes by up to 40 per cent, according to a new systematic review of the evidence.
The Indian press is reporting that Danone is in “advanced talks” to buy the nutrition division of billion-dollar Indian pharma-focused firm, Wockhardt’s, for a price as high as €180m.
A New Orleans-based biotech firm on a mission to commercialize “novel evidence-based prebiotic products” is aiming to bring its first products to market next year.
Antibiotics may achieve better results at preventing recurrent urinary tract infections, but they also increase the risk of antibiotic resistance three-fold, according to new research.
Adult entertainment giant Penthouse has branched out into the dietary supplements market with the launch of Penthouse Shots, liquid supplements claiming to “ignite sexual wellness”.
EFSA health claim opinion
Kraft Foods Europe is the second company to win a positive article 13.5 proprietary and emerging science health claim opinion from the European Food Safety Authority (EFSA) with a submission linking starch and glycaemic response in baked products.
The attorney representing Shaping Beauty – the recipient of a recent FDA warning letter claiming multiple violations of the Federal Food, Drug and Cosmetic Act – says her client is cooperating fully with the FDA.
The US arm of Israeli biotech firm Enzymotec says it is confident of sustaining double-digit growth in sales of krill oil as awareness of its multiple benefits grows.